New cell therapy trial targets Hard-to-Treat stage IV cancers
Disease control
Completed
This early-phase trial tested a combination of immune cells (cellular immunotherapy) in 9 people with stage IV solid tumors that had not responded to standard treatments. The main goal was to check safety and side effects, while also looking at whether the therapy could shrink tu…
Phase: PHASE1 • Sponsor: Seoul Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC